InvestorsHub Logo
Followers 230
Posts 14753
Boards Moderated 1
Alias Born 03/29/2014

Re: sentiment_stocks post# 81203

Friday, 10/28/2016 12:41:32 PM

Friday, October 28, 2016 12:41:32 PM

Post# of 706900
Well it could be for that...

http://newsroom.ucla.edu/releases/ucla-researchers-create-a-promising-new-treatment-for-the-deadliest-form-of-brain-cancer

But in that combination they used, it didn't use Linda Liau's dendritic cell vaccine.
It used the chemotherapy drug decitabine and reprogrammed t cells. The t cells were reprogrammed with a gene targeting New York esophageal squamous carcinoma (NY-ESO-1).

However, in this study published in the summer of this year, they did use the DC vaccine with a PD-1 mAb blockade (like BMY's Opdivo).

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951098/

So there's that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News